Interview with Dr. Cristoph Correll

What are the most important trends in CNS clinical trials? What lies ahead in 2019 and beyond?

Christoph U. Correll, MD, a member of WCG’s Scientific Leadership Team, shared his thoughts in a recent conversation with Mark Opler, MD, PhD, chief research officer at WCG-MedAvante-ProPhase. Dr. Correll is both a clinical psychiatrist (for both adults and children) and a clinical scientist. His work focuses on the identification, characterization and treatment of adults and youths with severe psychiatric disorders. His particular area of expertise is psychopharmacology.

Previous Video
Interview with Dr. Leslie Citrome
Interview with Dr. Leslie Citrome

Next Flipbook
Clinical Trial Recruitment Practices: The Evolution of Ethical Considerations
Clinical Trial Recruitment Practices: The Evolution of Ethical Considerations

Benchmark your study enrollment versus competitors

Get Benchmark Data